abstract |
A cyclohexylsulfonamide compound that is a platelet activating factor (PAF) receptor antagonist. The compounds can be useful, for example, in the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular and immune disorders. |